The above chart looks terrible. Monday seems like a dead cat bounce. Is that a death cross at the end of last week? Today again the stock closes at or near the daily lows suggesting more downside tomorrow.
The stock is trading 17% below the recent $8 secondary offering. This is a large psychological negative for the investors.
Several analysts have 12 month targets of $13 or more. I see that as unrealistic and expect one or more to lower the price target.
The company did one investor conference in the last quarter. (Two if you want to include the fireside chat with Craig-Hallum)
No new or enhanced product announcements since Andy Sealfon left. The super26 is Andy's brainchild. Against this background R&D has gone up substantially.